Cabpin Tablet 60/10 mg
Fimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
MFDS item code 201603155 · Approved 2016.05.31
Treatment of essential hypertension inadequately controlled with fimasartan monotherapy
This medicine can help patients with essential hypertension, whose blood pressure is not sufficiently controlled by monotherapy with pimasartan potassium. It is used to effectively manage hypertension to stabilize blood pressure and reduce the risk of cardiovascular disease.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted with fimasartan before starting this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 30/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy or 30/5 mg. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or 60/5 mg. Patients taking fimasartan and amlodipine concomitantly may switch to this medicine (a combination product with the same strengths of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy have not been established in pediatric and adolescent patients aged 18 years or younger.
This medicine can cause serious harm or death to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters. Therefore, if pregnancy is confirmed, the medication should be stopped immediately. This medicine should not be used by individuals who are allergic to its active ingredients or similar components, pregnant or breastfeeding women, patients on renal dialysis, patients with moderate to severe liver impairment, patients with obstructive biliary disease, certain kidney and diabetic patients, lactose intolerant patients, patients with severe aortic stenosis, and patients in a state of shock. Caution should be exercised when administering this medication to patients with low blood volume or sodium levels, impaired renal function, renal artery hypertension, patients with aortic or mitral valve stenosis, primary hyperaldosteronism, severe hypotension, the elderly, and patients with an allergy to Yellow No. 4. Side effects such as dizziness, headache, facial swelling, urinary disturbances, and insomnia may occur when taking this medicine, and serious renal issues or blood pressure drops may occur rarely; thus, any unusual symptoms should be reported to a doctor immediately. Particularly, if the blood pressure drops too low or severe side effects occur, medication should be stopped immediately and appropriate treatment obtained. This medicine can interact with other antihypertensives, potassium-sparing diuretics, lithium, NSAIDs, etc., so if other medications are being taken, it is essential to inform the doctor. If pregnant or breastfeeding, using this medicine may pose risks to the fetus and newborn, so consultation with a doctor is required before use and cessation of the medication or breastfeeding may be necessary. The safety and efficacy for children under 18 years have not been established, and elderly patients or those with severe liver impairment require dosage adjustments and caution. In cases of overdose, hypotension and heart problems may arise, necessitating immediate medical assistance, and generally, dialysis is not effective.
Not everyone experiences these, and they can vary from person to person.
This medicine is sensitive to light, so it should be stored in a container that blocks light. Additionally, it is advisable to store the medicine at room temperature between 1 degree and 30 degrees Celsius. Proper storage will maintain the medicine's efficacy and safety.
Yellow apple-shaped film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Fimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
Fimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Fimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Fimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.